Abiopharma

OVID THERAPEUTICS INC. (OVID)

Symbol	OVID
Name	OVID THERAPEUTICS INC.
Sector	HEALTH CARE
Region	North America
Industry	Biotechnology: Pharmaceutical Preparations
Address	1460 BROADWAY,SUITE 15021, NEW YORK, New York, 10036, United States
Telephone	+1 646 661-7661
Fax	—
Email	—
Website	https://www.ovidrx.com
Incorporation	UNDEFINED
Incorporated On	—
Employees	—
Fiscal Year	—
Public Since	—
Exchanges	NASDAQ
Auditor	—
Audit Status	NOT PROVIDED
Reporting Status	—
CIK	0001636651
Description	Ovid Therapeutics Inc is a biopharmaceutical company. The firm is primarily engaged in developing impactful medicines for patients and families living who are suffering from epilepsies, seizure-related disorders, and neurological disorders. It is targeting disorders such as intellectual disability, severe speech impairment, problems with movement and balance, sleep disorders and anxiety to transform the patients life. Additional info from NASDAQ: Ovid Therapeutics Inc is a biopharmaceutical company. The firm is primarily engaged in developing impactful medicines for patients and families living who are suffering from epilepsies, seizure-related disorders, and neurological disorders. It is targeting disorders such as intellectual disability, severe speech impairment, problems with movement and balance, sleep disorders and anxiety to transform the patients life.

2026-06-11 13:03

(99% Neutral) OVID THERAPEUTICS INC. (OVID) Announces Regulatory Update

2026-06-04 11:01

Ovid Therapeutics Inc. - Ovid Therapeutics to Participate in Upcoming Investor Conferences

2026-06-04 11:00

Ovid Therapeutics to Participate in Upcoming Investor Conferences

2026-06-03 11:03

(99% Neutral) OVID THERAPEUTICS INC. (OVID) Announces New Board Appointment

2026-06-03 11:00

Ovid Therapeutics Inc. - Ovid Therapeutics Appoints Leading Physician-Scientist and Biotech Innovator Anna Greka, M.D., Ph.D., to Board of Directors

2026-06-03 11:00

Ovid Therapeutics Appoints Leading Physician-Scientist and Biotech Innovator Anna Greka, M.D., Ph.D., to Board of Directors

2026-05-15 17:27

New Form SCHEDULE 13G/A - Ovid Therapeutics Inc. Filed: 2026-05-15 AccNo: 0000919574-26-003481 Size: 13 KB

2026-05-15 12:58

New Form SCHEDULE 13G - Ovid Therapeutics Inc. Filed: 2026-05-15 AccNo: 0001580642-26-003200 Size: 15 KB

2026-05-15 09:04

New Form SCHEDULE 13G - Ovid Therapeutics Inc. Filed: 2026-05-15 AccNo: 0000919574-26-003209 Size: 17 KB

2026-05-15 07:32

New Form SCHEDULE 13G - Ovid Therapeutics Inc. Filed: 2026-05-15 AccNo: 0001193125-26-225184 Size: 127 KB

No clinical trials found for this company.

No clinical products found for this company.